Search

everythinglearnresearchcommunity

for

Search:↓

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Platelet-rich plasma may improve vitiligo treatment when used with phototherapy.

N-acetyl-cysteine shows promise in treating various diseases and may improve skin and hair conditions, but more research is needed on dosages and long-term effects.

Genetics, stress, and health issues can cause early hair greying, which affects self-esteem, and there's no cure, only hair dye.

Certain drugs may cause vitiligo, so patients should be monitored.

Topical tofacitinib is a safe and effective treatment for autoimmune skin disorders.

The document concludes that various dermatological treatments and drugs can cause skin reactions and side effects.

Cancer survivors need better skin care to improve their quality of life.

Upadacitinib improved multiple immune-related conditions in one patient.

The document lists various dermatology topics, treatments, and diagnostic methods.

Dermatological conditions are complex, and treatments have mixed results.

Upadacitinib effectively treated severe atopic dermatitis, vitiligo, and alopecia areata in one patient.

Certain skin and family history markers predict vitiligo severity and treatment needs.

Keratinocyte stem cells are crucial for skin renewal and have potential in wound healing and tissue regeneration.

Recognize and treat hair loss conditions that mimic androgenetic alopecia by identifying warning signs and using proper tools.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

Mesenchymal stem cells improve skin appearance and structure in dermatology and aesthetic medicine.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.

DALL-E 2 is only accurate for acne in pediatric dermatology and needs better data for other conditions.

The document explains various skin conditions and their treatments.

Chemotherapy causes hair loss by damaging hair follicles and stem cells, with more research needed for prevention and treatment.

The document concludes that understanding hair structure is key to diagnosing hair abnormalities and recommends gentle hair care for management.

The telogen phase of hair growth is active and important for preparing hair follicles for regeneration, not just a resting stage.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

Manipulating the catagen and telogen phases of hair growth could lead to treatments for hair disorders.

Chemotherapy often causes temporary hair loss, which is distressing and needs better treatment and support.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Treatments for melanin disorders exist, but more effective options needed.

Antioxidants may help fight oxidative stress linked to autoimmune skin diseases.

Niosomes are promising for skin drug delivery, offering benefits like improved drug penetration and stability.